Recombinant human albumin - Recombumin®

Novozymes' animal-free, recombinant albumin (rAlbumin) range helps pharmaceutical drug medical device manufacturers deliver safe and affordable product improvements in a variety of applications.

Recombumin^®Prime
rAlbumin human USP-NF*.

For drug and vaccine manufacturing - Novozymes is the world's first and only supplier of commercial, animal-free recombinant human albumin.

Recombumin^® Alpha
rAlbumin human USP-NF*

For drug, vaccine and device manufacturing Developed to deliver quality and unprecedented performance benefits in our customers' applications.

*Meets National Formulary (NF) standards as published by United States Pharmacopeia (USP).

PRODUCT NAME CHANGE

Introducing a new brand and visual identity for our recombinant albumin (rAlbumin) portfolio. All rAlbumin products will now sit under the well-established Recombumin brand. Read more

WORLD’S FIRST

Novozymes Biopharma sets gold standard as suppliers of world's first USP-NF compliant recombinant human albumin

NEW DRAFT GUIDANCE FROM FDA

FDA signals intent to require manufacturers of all drugs made using blood and plasma-derived products including human serum albumin – to warn on labels of the risk regarding viral and prion disease transmission

Recombinant human albumin - Recombumin®

Novozymes' animal-free, recombinant albumin (rAlbumin) range helps pharmaceutical drug medical device manufacturers deliver safe and affordable product improvements in a variety of applications.

PRODUCT NAME CHANGE

WORLD’S FIRST

NEW DRAFT GUIDANCE FROM FDA

LATEST PRESENTATIONS